IDO1 and neoplasm: Indoleamine 2,3-dioxygenase 1 (IDO1) drives tumor immunosuppression in HGSOC by depleting local tryptophan and producing kynurenine inhibition, which is responsible for the downregulation of CD8+ tumor infiltrating lymphocytes (TILs) (Munn et al., 2016).